Literature DB >> 26711846

Active Surveillance for Small Renal Masses: A Review of the Aims and Preliminary Results of the DISSRM Registry.

Matthew R Danzig1, Peter Chang2, Andrew A Wagner2, Mohamad E Allaf3, James M McKiernan4, Phillip M Pierorazio3.   

Abstract

Active surveillance is an increasingly accepted treatment modality for select patients with small renal masses. The DISSRM (delayed intervention and surveillance for small renal masses) registry is a multi-institutional, prospectively collected data repository which includes patients who select active surveillance for their small renal masses, as well as others who select immediate intervention. Preliminary results from the registry suggest oncological equivalence of active surveillance and surgical modalities in the intermediate term. Additionally, the registry provides the first published data regarding trends in renal function among patients undergoing active surveillance. On average, these patients experience a decline in renal function, and their renal functional outcomes are superior to those of patients undergoing radical nephrectomy, but do not significantly differ from those of patients undergoing partial nephrectomy.

Entities:  

Keywords:  Glomerular filtration rate; Nephrectomy; Renal neoplasms

Mesh:

Year:  2016        PMID: 26711846     DOI: 10.1007/s11934-015-0564-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  53 in total

1.  The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study.

Authors:  Lars Lund; Jacob Jacobsen; Mette Nørgaard; Joseph K McLaughlin; William J Blot; Michael Borre; Henrik T Sørensen
Journal:  J Urol       Date:  2009-05-17       Impact factor: 7.450

2.  Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy.

Authors:  Michael J Leveridge; Antonio Finelli; John R Kachura; Andrew Evans; Hannah Chung; Daniel A Shiff; Kimberly Fernandes; Michael A S Jewett
Journal:  Eur Urol       Date:  2011-06-24       Impact factor: 20.096

3.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

4.  Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older.

Authors:  Brian R Lane; Robert Abouassaly; Tianming Gao; Christopher J Weight; Adrian V Hernandez; Benjamin T Larson; Jihad H Kaouk; Inderbir S Gill; Steven C Campbell
Journal:  Cancer       Date:  2010-07-01       Impact factor: 6.860

Review 5.  Rationale for percutaneous biopsy and histologic characterisation of renal tumours.

Authors:  Alessandro Volpe; Antonio Finelli; Inderbir S Gill; Michael A S Jewett; Guido Martignoni; Thomas J Polascik; Mesut Remzi; Robert G Uzzo
Journal:  Eur Urol       Date:  2012-05-12       Impact factor: 20.096

6.  Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

7.  The natural history of renal functional decline in patients undergoing surveillance in the DISSRM registry.

Authors:  Crystal V Castañeda; Matthew R Danzig; Julia B Finkelstein; Arindam RoyChoudhury; Andrew A Wagner; Peter Chang; Phillip M Pierorazio; Mohamad E Allaf; James M McKiernan
Journal:  Urol Oncol       Date:  2015-01-16       Impact factor: 3.498

8.  Grade heterogeneity in small renal masses: potential implications for renal mass biopsy.

Authors:  Mark W Ball; Stephania M Bezerra; Michael A Gorin; Morgan Cowan; Christian P Pavlovich; Phillip M Pierorazio; George J Netto; Mohamad E Allaf
Journal:  J Urol       Date:  2014-06-21       Impact factor: 7.450

9.  Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival.

Authors:  Sevag Demirjian; Brian R Lane; Ithaar H Derweesh; Toshio Takagi; Amr Fergany; Steven C Campbell
Journal:  J Urol       Date:  2014-04-18       Impact factor: 7.450

10.  Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.

Authors:  Daniel Santos Arrontes; María Jesús Fernández Aceñero; Jesús Isidoro García González; Manuel Martín Muñoz; Pedro Paniagua Andrés
Journal:  J Urol       Date:  2008-01-25       Impact factor: 7.450

View more
  2 in total

1.  Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.

Authors:  Ridwan Alam; Hiten D Patel; Tijani Osumah; Arnav Srivastava; Michael A Gorin; Michael H Johnson; Bruce J Trock; Peter Chang; Andrew A Wagner; James M McKiernan; Mohamad E Allaf; Phillip M Pierorazio
Journal:  BJU Int       Date:  2018-08-09       Impact factor: 5.588

Review 2.  Small renal masses in the elderly: Contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategies.

Authors:  Malte W Vetterlein; Tarun Jindal; Andreas Becker; Marc Regier; Luis A Kluth; Derya Tilki; Felix K-H Chun
Journal:  Investig Clin Urol       Date:  2016-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.